PreCancer Atlas:
From Biology to Cancer Interception

Moderated by: Jing Peng, PhD
Cancer Prevention Research
Recorded: 09/11/2023

Featuring key leaders of the PreCancer Atlas project, Drs. Eduardo Vilar-Sanchez, Anirban Maitra, Ernest Hawk, Sudhir Srivastava, Ken Lau, Jayant Rane, Beth A. Helmink, Kevin Monahan, Elena Tosti, and Neeha Zaidi; the panel discusses new insights emerging about cancer’s origins and evolution, and how these advances could inform cancer interception at earlier stages or be used in the development of preventative treatments.

For articles related to the PreCancer Atlas, read the collection.

About the Featured Speakers:

Eduardo Vilar-Sanchez, M.D., Ph.D., is a Professor, Chair ad interim, Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences at The University of Texas MD Anderson Cancer Center.

Anirban Maitra, M.B.B.S., is a Sheikh Khalifa Bin Zayed Al Nahyan Distinguished University Chair in Cancer Research, Professor of Pathology and Translational Molecular Pathology, Scientific Director, Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research at The University of Texas MD Anderson Cancer Center.

Ernest Hawk, M.D., M.P.H., is a Vice President & Division Head, Cancer Prevention & Population Sciences, Boone Pickens Distinguished Chair for Early Prevention of Cancer at The University of Texas MD Anderson Cancer Center.

Sudhir Srivastava, Ph.D., M.P.H., is a Chief, Cancer Biomarkers Research Group, Division of Cancer Prevention at National Cancer Institute, National Institutes of Health.

Ken Lau, Ph.D., is a Professor of Cell & Developmental Biology, Professor of Surgery at Vanderbilt University School of Medicine.

Jayant Rane, M.B.B.S, MRes, MRCP, Ph.D., is a NIHR Clinical Lecturer, Swanton Lab, Cancer Evolution & Genome Instability Lab at University College London & The Francis Crick Institute.

Beth A. Helmink, M.D., Ph.D., F.A.C.S., is an Assistant Professor, Department of Surgical Oncology, Division of Surgery at The University of Texas MD Anderson Cancer Center.

Kevin Monahan, Ph.D., is a Consultant Gastroenterologist at the Lynch Syndrome, Polyposis Registry & Family Cancer Clinic & the Wolfson Unit for Endoscopy, Clinical Scientific Officer at St Mark’s Hospital, Honorary Senior Clinical Lecturer at Imperial College London.

Elena Tosti, Ph.D., is an Associate, Department of Cell Biology, Michael F. Price Center for Genetic & Translational Medicine at Albert Einstein College of Medicine.

Neeha Zaidi, M.D., is an Assistant Professor, Sidney Kimmel Comprehensive Cancer Center, Gastrointestinal Immunology at The Johns Hopkins Hospital.